Market Overview

Earnings Outlook For AngioDynamics


On Tuesday, September 29, AngioDynamics (NASDAQ: ANGO) will release its latest earnings report. Decipher the announcement with Benzinga's help.

Earnings and Revenue

Based on management's projections, AngioDynamics analysts modeled for a loss of $0.07 per share on sales of $65.10 million. AngioDynamics EPS in the same period a year ago totaled $0.08. Revenue was $66.04 million. The Wall Street estimate would represent a 187.5% decline in the company's earnings per share. AngioDynamics's reported EPS has stacked up against analyst estimates in the past like this:

Quarter Q4 2020 Q3 2020 Q2 2020 Q1 2019
EPS Estimate -0.06 -0.03 0.02 0.04
EPS Actual -0.06 0.01 0.06 0.08
Revenue Estimate 64.30 M 68.55 M 71.28 M 67.52 M
Revenue Actual 58.33 M 69.78 M 70.00 M 66.04 M

Stock Performance

Over the past 52-week period, shares of AngioDynamics have declined 43.45%.

Considering these returns, long-term shareholders will likely be feeling neutral going into this earnings release.

Don't be surprised to see the stock move on comments made during its conference call. AngioDynamics is scheduled to hold the call at 08:00:00 ET and can be accessed here:


Related Articles (ANGO)

View Comments and Join the Discussion!

Posted-In: Earnings